Navigation Links
New UK study shows potential for targeting aggressive breast cancers
Date:2/11/2014

LEXINGTON, Ky. (Feb. 10, 2014) A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.

Triple-negative breast cancer has an activated EMT program, which is a process that provides cells with the increased plasticity (or flexibility) to adapt to stressed environments during embryonic development, wound healing, tissue fibrosis and metastasis. EMT provides tumor cells with stem cell-like characteristics, making them resistant to therapeutics and increasing their chances for early metastasis.

Triple-negative breast cancer in particular is associated with an aggressive clinical history, development of recurrence, distant metastasis and shorter patient survival, especially in younger women. It lacks effective targeted therapies and often displays early metastatic spread to brain and lung, sites known to be associated with an estimated 5-year survival of less than 20 percent.

Published in Cancer Cell, the study found that the nuclear protein Twist acts similarly to a virus protein. Using protein purification, Zhou's team identified that Twist interacted with a key nuclear transcription regulator BRD4. When many DNA viruses (such as papillomaviruses) enter into human "host" cells during infection, they hijack host cell machinery to replicate and synthesis their viral DNA and proteins. BRD4 is the virus's favored molecule and is often seized by DNA papillomaviruses for gene transcription during replication and growth.

Twist uses a similar strategy to recruit BRD4 to the genomic regions that are regulated by Twist. Many of these genomic regions contain oncogenes, such as those of survival proteins, growth factors and molecules that enhance cell migration and invasion. By recruiting BRD
'/>"/>

Contact: Allison Perry
allison.perry@uky.edu
859-323-2399
University of Kentucky
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UNC study reveals potential route to bladder cancer diagnostics, treatments
2. Dartmouth study provides first global evidence that foreign aid boosts public opinion
3. Study: Resilience in parents of children undergoing stem cell transplant
4. Grant supports Cedars-Sinai study of possible links between air pollution and brain cancer
5. Study provides surprising new clue to the roots of hunger
6. Study identifies protein to repair damaged brain tissue in MS
7. Ice ages arctic tundra lush with wildflowers for woolly mammoths, study finds
8. Director of Womens Guild Lung Institute awarded grant to study treatment for lung disease
9. Columbia study finds hospitals dont follow infection prevention rules
10. Penn study reveals genetics impact risk of early menopause among some female smokers
11. New study finds feeling in control can help you live longer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 According to the American Cancer Society, ... in the United States in 2014. (1) NTC ... the mortgage and financial industry, has long been a proponent ... and the company has further demonstrated its commitment by participating ... & Tarpon Springs event to increase awareness and fundraising efforts ...
(Date:7/30/2014)... 30, 2014 A formal complaint ... Office against the maker of the dialysis products ... Medical Care defrauded the state, its residents, physicians ... dialysates, before they were recalled in 2012. There ... these products pending in the U.S. District Court, ...
(Date:7/30/2014)... July 29, 2014 (HealthDay News) -- A simple blood ... spina bifida, new research finds. The test would ... in a pregnant women,s red blood cells. The findings from ... -- could help doctors predict the risk of serious birth ... to the proper development of a growing fetus. In ...
(Date:7/30/2014)... 30, 2014 (HealthDay News) -- ,Middle-aged adults with a ... likely as others to develop severe memory problems later ... British researchers said their findings could help doctors identify ... from help for problem drinking. "We already know ... of current alcohol consumption -- that understanding is based ...
(Date:7/30/2014)... Loffler Companies, the leading business technology and services ... new production printing machines from Konica Minolta and Canon ... better. , With blazing 100 page-per-minute output speed in ... press raises the bar in digital productivity, saves space ... costs with simple operation and powerful in-line finishing. The ...
Breaking Medicine News(10 mins):Health News:NTC Takes Action Against Cancer With 5th Consecutive Relay For Life of Palm Harbor & Tarpon Springs, Raises Over $12,000 for Cancer Research 2Health News:NTC Takes Action Against Cancer With 5th Consecutive Relay For Life of Palm Harbor & Tarpon Springs, Raises Over $12,000 for Cancer Research 3Health News:NTC Takes Action Against Cancer With 5th Consecutive Relay For Life of Palm Harbor & Tarpon Springs, Raises Over $12,000 for Cancer Research 4Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 2Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 3Health News:Blood Test Might Help Prevent Certain Birth Defects 2Health News:Adults Who've Abused Alcohol May Be at Risk for Memory Problems 2Health News:Loffler Companies Introduces New Konica Minolta bizhub PRESS C1085/C1100 and Canon imagePRESS C800/C700 Devices 2Health News:Loffler Companies Introduces New Konica Minolta bizhub PRESS C1085/C1100 and Canon imagePRESS C800/C700 Devices 3
... Research Collaborative for Health, both in Ann Arbor, have ... disparities in access to liver transplantation among racial and ... of Liver Transplantation , a journal published by ... Study of Liver Diseases (AASLD). Organ allocation in ...
... Aug. 19 (HealthDay News)-- There were no smiles on the faces ... waiting on line for help from the Oregon Employment Department were ... lecture from a middle-aged woman, who leaned in close and whispered ... a lot of unhappy, stressed people here." At rows of ...
... ARBOR, Mich. A team of University of Michigan scientists ... lifespan of roundworms. Scientists who study aging have long known ... the goal is to find less drastic ways to achieve ... promising early evidence that scientists may succeed at finding targets ...
... Reporter , WEDNESDAY, Aug. 18 (HealthDay News) -- Quitting ... many headache-prone teens ease their suffering, new research suggests. ... between those three lifestyle factors and recurrent headaches among ... number of headaches teens get and forestall headaches for ...
... more than 1,800 years reduced the gastrointestinal side effects ... of the cancer treatment, Yale University researchers report. ... herbs, called PHY906, and is based on a herbal ... nausea, vomiting and diarrhea. The study, published August 18 ...
... transplantation (HCT) cures many blood diseases, two-thirds of long-term ... the procedure, according to a recent study published ... the American Society of Hematology. Overall, these patients were ... a severe or life-threatening health condition, such as cardiovascular, ...
Cached Medicine News:Health News:Hispanics and Asians less likely to receive liver transplants 2Health News:Hispanics and Asians less likely to receive liver transplants 3Health News:Jobless and Stressed but Holding Out Hope 2Health News:Discovery may aid search for anti-aging drugs 2Health News:Discovery may aid search for anti-aging drugs 3Health News:Bad Habits Tied to Recurrent Headaches in Teens 2Health News:Bad Habits Tied to Recurrent Headaches in Teens 3Health News:Chronic health conditions common for stem cell transplant survivors 2Health News:Chronic health conditions common for stem cell transplant survivors 3
(Date:7/29/2014)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life ... total revenues of $39.8 million for the second quarter ... of $24.5 million for the second quarter of 2013. ... sold on May 30, 2014, has been accounted for ... been excluded from continuing operations for all periods. ...
(Date:7/29/2014)...  EnteroMedics Inc. (NASDAQ: ETRM ), the ... obesity, metabolic diseases and other gastrointestinal disorders, today announced ... August 7, 2014 at 11:00 AM Eastern Time to ... 30, 2014 and to provide a business update. ... conference call may be accessed by dialing (877) 280-7473 ...
(Date:7/29/2014)... 2014  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... specific pathogens that cause serious infections and diseases, announced ... in the Company,s stock, the NYSE MKT (the "Exchange") ... practice. The Company stated that its policy is not ... Synthetic Biologics, Inc. Synthetic Biologics, Inc. (NYSE ...
Breaking Medicine Technology:Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 2Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 3Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 4Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 5Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 6Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 7Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 8Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 9Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 10Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 11Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 12Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 13Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 14Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 15Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 16EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2
... diagnosisTAMPA, Fla., May 14 Moffitt Cancer ... have signed a license agreement on phospholipid ... been granted exclusive worldwide rights to Moffitt,s interests in ... maintenance fees, and royalties on sales. Moffitt and Frantz ...
... indicate statistically significant improvement in ACR20 responses over ... MEDX ) today announced that the ... active rheumatoid arthritis (RA) receiving methotrexate successfully met ... recently completed 70-patient multi-center, randomized, double-blind, placebo-controlled Phase ...
Cached Medicine Technology:Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 3Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 4
... benefits of fibre bronchoscopy: The HF-compatible V ... all other fibre bronchoscopes are measured., ... PENTAX, including the FB-19TV, FB-18V and FB-15V ... and the pediatric FB-8V, offer much better ...
... therapeutic fiberoptic bronchoscopes offers ... channel with a slim ... channel allows for improved ... of cytology brushes. The ...
... from the latest 60 series bronchoscopes., ... range, focussing on providing clinicians with ... Olympus has a impressive range of ... in the respiratory tract to meet ...
... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
Medicine Products: